Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs HBAI 20 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2017 Status changed from planning to recruiting.
- 03 May 2016 New trial record